share_log

京新药业(002020.SZ):公司暂未有基因治疗方向的布局

Zhejiang Jingxin Pharmaceutical (002020.SZ): The company has not yet made any plans for gene therapy.

Gelonghui Finance ·  Feb 18 09:21

On February 18, Glonghui reported that Zhejiang Jingxin Pharmaceutical (002020.SZ) stated on the investor interaction platform that the company currently does not have any plans for gene therapy.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 251

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.